FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385840219> ?p ?o ?g. }

• W4385840219 endingPage "50" @default.
• W4385840219 startingPage "50" @default.
• W4385840219 abstract "Type 2 diabetes mellitus (T2DM) is the world's most common metabolic disease. The development of T2DM is mainly caused by a combination of two factors: the failure of insulin secretion by the pancreatic β-cells and the inability of insulin-sensitive tissues to respond to insulin (insulin resistance); therefore, the disease is indicated by a chronic increase in blood glucose. T2DM patients can be treated with mono- or combined therapy using oral antidiabetic drugs and insulin-replaced agents; however, the medication often leads to various discomforts, such as abdominal pain, diarrhea or constipation, nausea and vomiting, and hypersensitivity reactions. A biguanide drug, metformin, has been used as a first-line drug to reduce blood sugar levels. Sulfonylureas work by blocking the ATP-sensitive potassium channel, directly inducing the release of insulin from pancreatic β-cells and thus decreasing blood glucose concentrations. However, the risk of the failure of sulfonylurea as a monotherapy agent is greater than that of metformin or rosiglitazone (a thiazolidinedione drug). Sulfonylureas are used as the first-line drug of choice for DM patients who cannot tolerate metformin therapy. Other antidiabetic drugs, thiazolidinediones, work by activating the peroxisome proliferator-activated receptor gamma (PPARγ), decreasing the IR level, and increasing the response of β-cells towards the glucose level. However, thiazolidines may increase the risk of cardiovascular disease, weight gain, water retention, and edema. This review article aims to discuss case reports on the use of metformin, sulfonylureas, and thiazolidinediones in DM patients. The literature search was conducted on the PubMed database using the keywords 'metformin OR sulfonylureas OR thiazolidinediones AND case reports', filtered to 'free full text', 'case reports', and '10 years publication date'. In some patients, metformin may affect sleep quality and, in rare cases, leads to the occurrence of lactate acidosis; thus, patients taking this drug should be monitored for their kidney status, plasma pH, and plasma metformin level. Sulfonylureas and TZDs may cause a higher risk of hypoglycemia and weight gain or edema due to fluid retention. TZDs may be associated with risks of cardiovascular events in patients with concomitant T2DM and chronic obstructive pulmonary disease. Therefore, patients taking these drugs should be closely monitored for adverse effects." @default.
• W4385840219 created "2023-08-16" @default.
• W4385840219 creator A5037901426 @default.
• W4385840219 creator A5065807673 @default.
• W4385840219 creator A5066004564 @default.
• W4385840219 creator A5067236356 @default.
• W4385840219 date "2023-08-15" @default.
• W4385840219 modified "2023-09-26" @default.
• W4385840219 title "Review of the Case Reports on Metformin, Sulfonylurea, and Thiazolidinedione Therapies in Type 2 Diabetes Mellitus Patients" @default.
• W4385840219 cites W1822662507 @default.
• W4385840219 cites W1964434504 @default.
• W4385840219 cites W1965819590 @default.
• W4385840219 cites W1971438651 @default.
• W4385840219 cites W1976382670 @default.
• W4385840219 cites W1988386882 @default.
• W4385840219 cites W1994030315 @default.
• W4385840219 cites W1996546989 @default.
• W4385840219 cites W1997236696 @default.
• W4385840219 cites W2019141360 @default.
• W4385840219 cites W2022180805 @default.
• W4385840219 cites W2050621767 @default.
• W4385840219 cites W2067022504 @default.
• W4385840219 cites W2068719866 @default.
• W4385840219 cites W2071889472 @default.
• W4385840219 cites W2092864973 @default.
• W4385840219 cites W2117617740 @default.
• W4385840219 cites W2119390581 @default.
• W4385840219 cites W2123472586 @default.
• W4385840219 cites W2141355026 @default.
• W4385840219 cites W2143066955 @default.
• W4385840219 cites W2161178286 @default.
• W4385840219 cites W2215629512 @default.
• W4385840219 cites W2431952300 @default.
• W4385840219 cites W2475311184 @default.
• W4385840219 cites W2560179984 @default.
• W4385840219 cites W2611137524 @default.
• W4385840219 cites W2781265137 @default.
• W4385840219 cites W2783296927 @default.
• W4385840219 cites W2784740975 @default.
• W4385840219 cites W2805770876 @default.
• W4385840219 cites W2904280964 @default.
• W4385840219 cites W2937749211 @default.
• W4385840219 cites W2946710786 @default.
• W4385840219 cites W2992492753 @default.
• W4385840219 cites W3005580997 @default.
• W4385840219 cites W3026050705 @default.
• W4385840219 cites W3047056909 @default.
• W4385840219 cites W3081655479 @default.
• W4385840219 cites W3112971449 @default.
• W4385840219 cites W3118777720 @default.
• W4385840219 cites W3121807119 @default.
• W4385840219 cites W3149084183 @default.
• W4385840219 cites W3172523949 @default.
• W4385840219 cites W3183548861 @default.
• W4385840219 cites W4200215705 @default.
• W4385840219 cites W4200349269 @default.
• W4385840219 cites W4220931730 @default.
• W4385840219 cites W4220975971 @default.
• W4385840219 cites W4233007762 @default.
• W4385840219 cites W4242933564 @default.
• W4385840219 cites W4280517549 @default.
• W4385840219 cites W4280633899 @default.
• W4385840219 cites W4287522280 @default.
• W4385840219 cites W4295137925 @default.
• W4385840219 cites W4297405150 @default.
• W4385840219 cites W4303629116 @default.
• W4385840219 cites W4308423704 @default.
• W4385840219 cites W4309656541 @default.
• W4385840219 doi "https://doi.org/10.3390/medsci11030050" @default.
• W4385840219 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37606429" @default.
• W4385840219 hasPublicationYear "2023" @default.
• W4385840219 type Work @default.
• W4385840219 citedByCount "0" @default.
• W4385840219 crossrefType "journal-article" @default.
• W4385840219 hasAuthorship W4385840219A5037901426 @default.
• W4385840219 hasAuthorship W4385840219A5065807673 @default.
• W4385840219 hasAuthorship W4385840219A5066004564 @default.
• W4385840219 hasAuthorship W4385840219A5067236356 @default.
• W4385840219 hasBestOaLocation W43858402191 @default.
• W4385840219 hasConcept C126322002 @default.
• W4385840219 hasConcept C134018914 @default.
• W4385840219 hasConcept C2776923340 @default.
• W4385840219 hasConcept C2777180221 @default.
• W4385840219 hasConcept C2777391703 @default.
• W4385840219 hasConcept C2777688063 @default.
• W4385840219 hasConcept C2778854520 @default.
• W4385840219 hasConcept C2779306644 @default.
• W4385840219 hasConcept C2780152017 @default.
• W4385840219 hasConcept C2780323712 @default.
• W4385840219 hasConcept C2910068830 @default.
• W4385840219 hasConcept C555293320 @default.
• W4385840219 hasConcept C71924100 @default.
• W4385840219 hasConcept C98274493 @default.
• W4385840219 hasConceptScore W4385840219C126322002 @default.
• W4385840219 hasConceptScore W4385840219C134018914 @default.
• W4385840219 hasConceptScore W4385840219C2776923340 @default.
• W4385840219 hasConceptScore W4385840219C2777180221 @default.
• W4385840219 hasConceptScore W4385840219C2777391703 @default.

• next